Halozyme Therapeutics, Inc.
Sales Per Share
| Fiscal Year | Sales Per Share |
|---|---|
| FY2016 | $1.15 |
| FY2017 | $2.28 |
| FY2018 | $1.06 |
| FY2019 | $1.36 |
| FY2020 | $1.89 |
| FY2021 | $3.02 |
| FY2022 | $4.69 |
| FY2023 | $6.18 |
| FY2024 | $7.84 |
| FY2025 | $11.27 |
Sales Per Share
| Fiscal Year | Sales Per Share |
|---|---|
| FY2016 | $1.15 |
| FY2017 | $2.28 |
| FY2018 | $1.06 |
| FY2019 | $1.36 |
| FY2020 | $1.89 |
| FY2021 | $3.02 |
| FY2022 | $4.69 |
| FY2023 | $6.18 |
| FY2024 | $7.84 |
| FY2025 | $11.27 |